XML 93 R49.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and License Agreements (Schedule of Unaudited Pro Forma Information) (Details) (Questcor and Cadence Pharmaceuticals, USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 28, 2014
Mar. 28, 2014
Questcor and Cadence Pharmaceuticals
   
Business Acquisition, Pro Forma Information [Line Items]    
Net sales, pro forma $ 815.3us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ 1,633.7us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Net (loss) income, pro forma $ 10.2us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ 70.5us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Basic (loss) earnings per share, pro forma (in usd per share) $ 0.09us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ 0.62us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Diluted (loss) earnings per share, pro forma (in usd per share) $ 0.09us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
$ 0.61us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember